Lymphedema following cancer therapy: overview and options

  • Michael Bernas
  • Saskia R. J. Thiadens
  • Betty Smoot
  • Jane M. Armer
  • Paula Stewart
  • Jay Granzow
Research Paper


This summit focusing on lymphedema following cancer therapy was held during the 7th International Symposium on Cancer Metastasis through the Lymphovascular System. It was unique for the inclusion of patients with lymphedema joining physicians, therapists, healthcare professionals, and researchers to highlight what is known and more importantly what is unknown about the current state of research and treatment in the United States. The session opened with an introduction to lymphedema and then explored the incidence of multiple cancer-related lymphedemas, imaging tools and techniques useful for the diagnosis of lymphatic system abnormalities, and the new findings concerning the genetics of cancer-related lymphedema. It closed with a review of advocacy for patients and healthcare professionals and both conservative and surgical treatment options, followed by a panel discussion and questions. The session provided important information and updates which will be of value for improving the rehabilitation and overall support of patients with cancer-related lymphedema.


Lymphedema Diagnosis Imaging Genetics Treatment Advocacy 


  1. 1.
    International Society of Lymphology (2016) The diagnosis and treatment of peripheral lymphedema: 2016 consensus document of the international society of lymphology. Lymphology 49:170–184Google Scholar
  2. 2.
    Armer JM, Stewart BR, Shook RP (2009) 30-month post-breast cancer treatment lymphoedema. J Lymphoedema 4(1):14–18PubMedPubMedCentralGoogle Scholar
  3. 3.
    Cormier JN, Askew RL, Mungovan KS, Xing Y, Ross MI, Armer JM (2010) Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema. Cancer 116(22):5138–5149CrossRefPubMedGoogle Scholar
  4. 4.
    Asellius G. De lactibus venis quarto vasorum mesaraicorum genere novo inuento, Mediolani, 1627, JB Biddellium. Reproduced in 1972 by Epistem Editrice, MilanoGoogle Scholar
  5. 5.
    Natale G, Bocci G, Ribatti D (2017) Scholars and scientists in the history of the lymphatic system. J Anat 231(3):417–429CrossRefPubMedGoogle Scholar
  6. 6.
    Kinmonth JB (1972) The lymphatics: diseases, lymphography and surgery. Williams & Wilkins, BaltimoreGoogle Scholar
  7. 7.
    Bernas M (2013) Imaging of the lymphatic system. In: Lymphedema management: the comprehensive guide for practitioners, 3rd edn. Thieme, New YorkGoogle Scholar
  8. 8.
    Witte CL, Witte MH, Unger EC, Williams WH, Bernas MJ, McNeill GC, Stazzone AM (2000) Advances in imaging of lymph flow disorders. Radiographics 20(6):1697–1719CrossRefPubMedGoogle Scholar
  9. 9.
    Yamamoto T, Matsuda N, Doi K, Oshima A, Yoshimatsu H, Todokoro T, Ogata F, Mihara M, Narushima M, Iida T, Koshima I (2011) The earliest finding of indocyanine green lymphography in asymptomatic limbs of lower extremity lymphedema patients secondary to cancer treatment: the modified dermal backflow stage and concept of subclinical lymphedema. Plast Reconstr Surg 128(4):314e–321eCrossRefPubMedGoogle Scholar
  10. 10.
    Dori Y, Keller MS, Fogel MA, Rome JJ, Whitehead KK, Harris MA, Itkin M (2014) MRI of lymphatic abnormalities after functional single-ventricle palliation surgery. AJR 203:426–431CrossRefPubMedGoogle Scholar
  11. 11.
    Rane S, Donahue PMC, Towse T, Ridner S, Chappell M, Jordi J, Gore J, Donahue MJ (2013) Clinical feasibility of noninvasive visualization of lymphatic flow with principles of spin labeling MR imaging: implications for lymphedema assessment. Radiology 269:893–902CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Brouillard P, Boon L, Vikkula M (2014) Genetics of lymphatic anomalies. J Clin Invest 124(3):898–904CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Connell FC, Gordon K, Brice G, Keeley V, Jeffery S, Mortimer PS, Mansour S, Ostergaard P (2013) The classification and diagnostic algorithm for primary lymphatic dysplasia: an update from 2010 to include molecular findings. Clin Genet 84:303–314CrossRefPubMedGoogle Scholar
  14. 14.
    Finegold DN, Schacht V, Kimak MA, Lawrence EC, Foeldi E, Karlsson JM, Baty CJ, Ferrell RE (2008) HGF and MET mutations in primary and secondary lymphedema. Lymphat Res Biol 6:65–68CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Finegold DN, Baty CJ, Knickelbein KZ, Perschke S, Noon SE, Campbell D, Karlsson JM, Huang D, Kimak MA, Lawrence EC, Feingold E, Meriney SD, Brufsky AM, Ferrell RE (2012) Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment. Clin Cancer Res 18(8):1–9CrossRefGoogle Scholar
  16. 16.
    Newman B, Lose F, Kedda M-A, Francois M, Ferguson K, Janda M, Yates P, Spurdle AB, Hayes SC (2012) Possible genetic predisposition to lymphedema after breast cancer. Lymphat Res Biol 10:2–13CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Fu MR, Conley YP, Axelrod D, Guth AA, Yu G, Fletcher J, Zagzag D (2016) Precision assessment of heterogeneity of lymphedema phenotype, genotypes and risk prediction. Breast 29:231–240CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Miaskowski C, Dodd M, Paul SM, West C, Hamolsky D, Abrams G, Cooper BA, Elboim C, Neuhaus J, Schmidt BL, Smoot B, Aouizeratet BE (2013) Lymphatic and angiogenic candidate genes predict the development of secondary lymphedema following breast cancer surgery. PLoS ONE 8(4):e60164CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Leung G, Baggott C, West C, Elboim C, Paul SM, Cooper BA, Abrams G, Dhruva A, Schmidt BL, Kober K, Merriman JD, Leutwyler H, Neuhaus J, Langford D, Smoot BJ, Aouizerat BE, Miaskowski C (2014) Cytokine candidate genes predict the development of secondary lymphedema following breast cancer surgery. Lymphat Res Biol 12(1):10–22CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Smoot B, Kober KM, Paul SM, Levine JD, Abrams G, Mastick J, Topp K, Conley YP, Miaskowski CA (2017) Potassium channel candidate genes predict the development of secondary lymphedema following breast cancer surgery. Nurs Res 66(2):85–94CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Tam K, Shen L, Munneke JR, Ackerson LM, Partee PN, Somkin CP, Andre M, Kutner SE, Thiadens SRJ, Kwan ML (2012) Clinician awareness and knowledge of BCRL in a large, integrated healthcare delivery setting. Breast Cancer Res Treat 131(3):1029–1038CrossRefPubMedGoogle Scholar
  22. 22.
    Lasinski BB, McKillip Thrift K, Squire D, Austin MK, Smith KM, Wanchai A, Green JM, Stewart BR, Cormier JN, Armer JM (2012) A systematic review of the evidence for complete decongestive therapy in the treatment of lymphedema from 2004 to 2011. PM&R 4(8):580–601CrossRefGoogle Scholar
  23. 23.
    Armer JM, Hulett JM, Bernas M, Ostby P, Stewart BR, Cormier JN (2013) Best practice guidelines in assessment, risk reduction, management, and surveillance for post-breast cancer lymphedema. Curr Breast Cancer Rep 5(2):134–144CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Fu MR, Deng J, Armer JM (2014) Putting evidence into practice: cancer-related lymphedema. Clin J Oncol Nurs 18(Suppl):68–79CrossRefPubMedGoogle Scholar
  25. 25.
    Boccardo F, Casabona F, De Cian F, Friedman D, Villa G, Bogliolo S, Ferrero S, Murelli F, Campisi C (2009) Lymphedema microsurgical preventive healing approach: a new technique for primary prevention of arm lymphedema after mastectomy. Ann Surg Oncol 16:703–708CrossRefPubMedGoogle Scholar
  26. 26.
    Box RC, Reul-Hirche HM, Bullock-Saxton JE, Furnival CM (2002) Physiotherapy after breast cancer surgery: results of a randomized controlled study to minimise lymphedema. Breast Cancer Res Treat 75:51–64CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V., part of Springer Nature 2018

Authors and Affiliations

  • Michael Bernas
    • 1
  • Saskia R. J. Thiadens
    • 2
  • Betty Smoot
    • 3
  • Jane M. Armer
    • 4
  • Paula Stewart
    • 5
    • 6
  • Jay Granzow
    • 7
    • 8
  1. 1.TCU and UNTHSC School of MedicineFort WorthUSA
  2. 2.National Lymphedema Network (NLN)NapaUSA
  3. 3.University of California San FranciscoSan FranciscoUSA
  4. 4.University of Missouri Sinclair School of NursingColumbiaUSA
  5. 5.Parkridge Medical Center RehabilitationChattanoogaUSA
  6. 6.Siskin Hospital for Physical RehabilitationChattanoogaUSA
  7. 7.Division of Plastic SurgeryUCLA David Geffen School of MedicineLos AngelesUSA
  8. 8.Harbor-UCLA Medical CenterLos AngelesUSA

Personalised recommendations